Skip to main content

What the FDA labels say about taking them together

Eltrombopag and eluxadoline

Eluxadoline's FDA label of July 16, 2024 names eltrombopag in its drug interactions section; the eltrombopag labels PlainMeds reads (2) do not name eluxadoline. The eluxadoline label: “Increased exposure to eluxadoline when coadministered with cyclosporine [ see Clinical Pharmacology () ]”

Check it at the source: the eltrombopag FDA label on DailyMed (effective December 18, 2025, Novartis Pharmaceuticals Corporation); the eluxadoline FDA label on DailyMed (effective July 16, 2024, Allergan, Inc.).

What does the eltrombopag label say about eluxadoline?

Eltrombopag's label (effective December 18, 2025) and its 1 other brand-application label do not name eluxadoline in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (PROMACTA), Novartis Pharmaceuticals Corporation, effective December 18, 2025 (SPL set 7714a0ed-34bb-46e6-a0a5-b363908b22c2), via openFDA; the full label on DailyMed

What does the eluxadoline label say about eltrombopag?

Eluxadoline label, drug interactions

OATP1B1 Inhibitors Clinical Impact: Increased exposure to eluxadoline when coadministered with cyclosporine [ see Clinical Pharmacology () ] … cyclosporine, gemfibrozil, antiretrovirals (atazanavir, lopinavir, ritonavir, saquinavir, tipranavir), rifampin, eltrombopag

Source: FDA drug label (Viberzi), NDA206940 (Abbvie), as published by Allergan, Inc., effective July 16, 2024 (SPL set 7821bd40-4c84-4984-951b-6436ae20421a), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

13Eltrombopag generic labelers
0Eluxadoline generic labelers
EltrombopagEluxadoline
Labeled forAnemiaIrritable bowel syndrome, Diarrhea
Boxed warningYesNo
Pharmacy cost (NADAC)$25.85 per tablet 50 mg tablet$28.09 per tablet 100 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?